Michael A. Stanga
Wichita State University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Michael A. Stanga.
Bioorganic & Medicinal Chemistry | 1995
William C. Groutas; Radhika Venkataraman; Lee S. Chong; James E. Yoder; Jeffrey B. Epp; Michael A. Stanga; Eun-Hong Kim
Abstract A series of isoxazoline derivatives were synthesized and investigated for their in vitro inhibitory activity towards human leukocyte elastase, cathepsin G and proteinase 3.
Archives of Biochemistry and Biophysics | 1992
William C. Groutas; Michael J. Brubaker; Rhadika Venkataraman; Jeffrey B. Epp; Michael A. Stanga; Jerald J. McClenahan
The interaction of a series of sulfonate and phosphate esters derived from N-hydroxysuccinimide with human leukocyte cathepsin G was investigated. The synthesized compounds were found to be time-dependent inhibitors of the enzyme. The composite interplay of steric and electronic effects leads to the formation of acyl enzymes of variable stability, ultimately resulting in partial or full recovery of enzymatic activity. Compounds acting via phosphorylation of the active site serine inactivated the enzyme rapidly and irreversibly.
Biochemical and Biophysical Research Communications | 1985
William C. Groutas; Michael J. Brubaker; M.E. Zandler; Michael A. Stanga; Tien L. Huang; J.C. Castrisos; J.P. Crowley
A series of amino acid-derived sulfonate salts have been synthesized. They were found to inactivate efficiently and selectively human leukocyte elastase. The sulfonate salts of the methyl esters of L-norleucine, L-norvaline and L-valine were the most potent. The enzyme is inactivated irreversibly with concomitant release of bisulfite ion. The results demonstrate for the first time that ionic compounds can indeed function as novel inhibitors for the serine proteinases.
Journal of Enzyme Inhibition | 1990
William C. Groutas; Michael A. Stanga; J.C. Castrisos; E.J. Schatz
Derivatives of hydantoin have been found to inactivate human leukocyte elastase irreversibly. Chymotrypsin and cathepsin G are also inhibited by these compounds.
Biochimica et Biophysica Acta | 1993
William C. Groutas; Radhika Venkataraman; Michael J. Brubaker; Jeffrey B. Epp; Lee S. Chong; Michael A. Stanga; Jerald J. McClenahan; Fusao Tagusagawa
A series of 3-(alkylthio)-N-hydroxysuccinimide derivatives was synthesized and their inhibitory activity towards human leukocyte elastase (HLE) was investigated. The interaction of the compounds having a 3-alkylthioether side chain (compounds 1 and 2) with HLE was found to involve rapid acylation of the enzyme, followed by total regain of enzymatic activity within 3 h. Interestingly, compounds 3-8, having an oxidized thioether side chain, were found to be highly effective, time-dependent, irreversible inhibitors of the enzyme. The k(obs)/I values for compounds 3-8 ranged between 890 and 24,000 M-1 s-1. These findings demonstrate that, unlike the physiological inhibitor of HLE (alpha-1-proteinase inhibitor), which is inactivated upon oxidation, low-molecular-weight compounds retain and/or show enhanced inhibitory activity towards HLE upon oxidation of the thioether side chain and lay the groundwork for the development of compounds that embody proteinase inhibitory and antioxidant activity.
Archives of Biochemistry and Biophysics | 1992
William C. Groutas; Michael J. Brubaker; Radhika Venkataraman; Michael A. Stanga
(RS)-Diethyl-2-benzyl-succinate was resolved using alpha-chymotrypsin. The two enantiomers were then elaborated to yield (S)-(+) and (R)-(-)-3-benzyl-N-[(methyl-sulfonyl)oxy]succinimide and the inhibitory activity of the two enantiomers toward human leukocyte elastase was subsequently determined. The k2/KI values for the R and S isomers were found to be 330 and 1500 M-1 s-1, respectively.
Bioorganic & Medicinal Chemistry Letters | 1992
William C. Groutas; Lee S. Chong; Jeffrey B. Epp; Radhika Venkataraman; Michael J. Brubaker; Michael A. Stanga; Eun-Hong Kim; Charles E. Keller
Abstract The interaction of a series of derivatives of cis-N-hydroxy-3-phenyl-2-isoxazoline-4,5-dicarboximide toward human leukocyte elastase and cathepsin G was investigated. Both enzymes were rapidly acylated and the corresponding acyl enzymes exhibited variable stability.
Bioorganic & Medicinal Chemistry Letters | 1993
William C. Groutas; James C. Castrisos; Michael A. Stanga; Rongze Kuang; Radhika Venkataraman; Jeffrey B. Epp; Michael J. Brubaker; Lee S. Chong
Abstract Several heterocyclic compounds derived from 3-hydroxypyridazopyrimidine-(I), 3-hydroxypyridopyrimidine-(II) and 3-hydroxyquinazoline-2,4(1H,3H)diones-(III) have been found to be time-dependent irreversible inhibitors of human leukocyte elastase.
Journal of Medicinal Chemistry | 1989
William C. Groutas; Michael J. Brubaker; Michael A. Stanga; J. C. Castrisos; J. P. Crowley; Schatz Ej
Journal of Medicinal Chemistry | 1985
William C. Groutas; Michael A. Stanga; Michael J. Brubaker; Tien L. Huang; Min K. Moi; Robert T. Carroll